Clinical Trial Update: A Study Testing the Use of a Perivascular Sirolimus Formulation (Sirogen) in ESRD Patients Undergoing AV Fistula Surgery [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating a perivascular sirolimus formulation (Sirogen) in end-stage renal disease patients undergoing arteriovenous fistula surgery ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Sirogen (Sirolimus)

Snippet

Sponsor: Vascular Therapies, Inc. | Conditions: Complication of Renal Dialysis, End Stage Renal Disease | Phase 3 | Status: COMPLETED